Peter C. Searson

Peter C. Searson

Auto-generated profile, based on publicly available information

Peter C. Searson

Institute for NanoBioTechnology, Johns Hopkins University

Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2011 in Nature Reviews Cancer
Verified
Journal Article
Closed access
PDF file
DWDenis Wirtz
Denis Wirtz
KKKonstantinos Konstantopoulos
Konstantinos Konstantopoulos
PSPeter C. Searson
Peter C. Searson

3 September 1993 in Science
Verified
Journal Article
Closed access
PDF file
TWT. M. Whitney
T. M. Whitney
PSP. C. Searson
P. C. Searson
JJJ. S. Jiang
J. S. Jiang
CCC. L. Chien
C. L. Chien
Arrays of ferromagnetic nickel and cobalt nanowires have been fabricated by electrochemical deposition of the metals into templates with nanometer-sized pores prepared by nuclear track etching. These systems display distinctive characteristics because of their one-dimensional microstructure. The preferred magnetization direction is perpendicular to the film plane. Enhanced coercivities as high as 680 oersteds and remnant magnetization up to 90 percent have also been observed.

12 February 2016 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
MKMoriah E. Katt
Moriah E. Katt
APAmanda L. Placone
Amanda L. Placone
AWAndrew D. Wong
Andrew D. Wong
ZXZinnia S. Xu
Zinnia S. Xu
PSPeter C. Searson
Peter C. Searson
In vitro tumor models have provided important tools for cancer research and serve as low-cost screening platforms for drug therapies; however, cancer recurrence remains largely unchecked due to metastasis, which is the cause of the majority of cancer related deaths. The need for an improved understanding of the progression and treatment of cancer has pushed for increased accuracy and physiological relevance of in vitro tumor models. As a result, in vitro tumor models have concurrently increased in complexity and their output parameters further diversified, since these models have progressed beyond simple proliferation, invasion, and cytotoxicity screens and have begun recapitulating critical steps in the metastatic cascade, such as intravasation, extravasation, angiogenesis, matrix remodeling, and tumor cell dormancy. Advances in tumor cell biology, 3D cell culture, tissue engineering, biomaterials, microfabrication, and microfluidics have enabled rapid development of new in vitro tumor models that often incorporate multiple cell types, extracellular matrix materials, and spatial and temporal introduction of soluble factors. Other innovations include the incorporation of perfusable microvessels to simulate the tumor vasculature and model intravasation and extravasation. The drive towards precision medicine has increased interest in adapting in vitro tumor models for patient-specific therapies, clinical management, and assessment of metastatic potential. Here, we review the wide range of current in vitro tumor models and summarize their advantages, disadvantages, and suitability in modeling specific aspects of the metastatic cascade and drug treatment.

14 September 2003 in Nature Materials
Verified
Journal Article
Closed access
PDF file
ASAliasger K. Salem
Aliasger K. Salem
PSPeter C. Searson
Peter C. Searson
KLKam W Leong
Kam W Leong

10 November 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
SKShyam B. Khatau
Shyam B. Khatau
CHChristopher M. Hale
Christopher M. Hale
PSP. J. Stewart-Hutchinson
P. J. Stewart-Hutchinson
MPMeet S. Patel
Meet S. Patel
CSColin L. Stewart
Colin L. Stewart
DWDenis Wirtz
Denis Wirtz
Defects in nuclear morphology often correlate with the onset of disease, including cancer, progeria, cardiomyopathy, and muscular dystrophy. However, the mechanism by which a cell controls its nuclear shape is unknown. Here, we use adhesive micropatterned surfaces to control the overall shape of fibroblasts and find that the shape of the nucleus is tightly regulated by the underlying cell adhesion geometry. We found that this regulation occurs through a dome-like actin cap that covers the top of the nucleus. This cap is composed of contractile actin filament bundles containing phosphorylated myosin, which form a highly organized, dynamic, and oriented structure in a wide variety of cells. The perinuclear actin cap is specifically disorganized or eliminated by inhibition of actomyosin contractility and rupture of the LINC complexes, which connect the nucleus to the actin cap. The organization of this actin cap and its nuclear shape-determining function are disrupted in cells from mouse models of accelerated aging (progeria) and muscular dystrophy with distorted nuclei caused by alterations of A-type lamins. These results highlight the interplay between cell shape, nuclear shape, and cell adhesion mediated by the perinuclear actin cap.

1 January 2013 in Frontiers in Neuroengineering
Verified
Journal Article
Open access
PDF file
AWAndrew D. Wong
Andrew D. Wong
MYMao Ye
Mao Ye
ALAmanda F. Levy
Amanda F. Levy
JRJeffrey D. Rothstein
Jeffrey D. Rothstein
DBDwight E. Bergles
Dwight E. Bergles
PSPeter C. Searson
Peter C. Searson
It has been more than 100 years since Paul Ehrlich reported that various water-soluble dyes injected into the circulation did not enter the brain. Since Ehrlich’s first experiments, only a small number of molecules, such as alcohol and caffeine have been found to cross the blood-brain barrier, and it remains the major roadblock to treatment of many central nervous system diseases. At the same time, many central nervous system diseases are associated with disruption of the blood-brain barrier that can lead to changes in permeability, modulation of immune cell transport, and trafficking of pathogens into the brain. Therefore advances in our understanding of the structure and function of the blood-brain barrier are key to advances in treatment of a wide range of central nervous system diseases. Over the past 10 years it has become recognized that the blood-brain barrier is a complex dynamic system that involves biomechanical and biochemical signaling between the vascular system and the brain. Here we reconstruct the structure, function, and transport properties of the blood-brain barrier from an engineering perspective. New insight into the physics of the blood-brain barrier could ultimately lead to clinical advances in the treatment of central nervous system diseases.